From physiology to pharmacy: Developments in the pathogenesis and treatment of recurrent urinary tract infections

Jennifer A. Silverman, Henry L. Schreiber, Thomas M. Hooton, Scott J. Hultgren

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

Urinary tract infections (UTIs) are common, and over half of women report having had at least one in their lifetime. Nearly a third of these women experience recurrent UTI episodes, but the mechanisms of these recurrences are not fully elucidated. Frequent use of antimicrobials for treatment and prevention of UTIs and other infections has contributed to the evolution of multidrug-resistant microorganisms globally. This is a looming worldwide crisis that has created an urgent need for novel strategies for the treatment and prevention of UTIs. Furthering our understanding of the mechanisms of recurrent UTIs, from both host and bacterial perspectives, will be paramount in developing targeted management strategies. In this review, we discuss recent findings regarding recurrent UTIs in women, including progress in our understanding of the mechanisms of recurrence as well as emerging treatments.

Original languageEnglish (US)
Pages (from-to)448-456
Number of pages9
JournalCurrent urology reports
Volume14
Issue number5
DOIs
StatePublished - Oct 2013

Keywords

  • Antibiotic resistance
  • FimH
  • Mannoside
  • Pilicide
  • Recurrent urinary tract infection
  • Stress response

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'From physiology to pharmacy: Developments in the pathogenesis and treatment of recurrent urinary tract infections'. Together they form a unique fingerprint.

  • Cite this